These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37592775)

  • 1. Bio-Functional Mesoporous Silica Nanoparticles as Nano-Structured Carriers in Cancer Theranostic Review on Recent Advancements.
    Gevariya D; Priya L; Mehta S; Patel V; Bhuva D; Panjwani D; Patel S; Ahlawat P; Dharamsi A; Patel A
    Curr Drug Targets; 2023; 24(12):934-944. PubMed ID: 37592775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silica-based mesoporous nanoparticles for controlled drug delivery.
    Kwon S; Singh RK; Perez RA; Abou Neel EA; Kim HW; Chrzanowski W
    J Tissue Eng; 2013; 4():2041731413503357. PubMed ID: 24020012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel.
    Khosravian P; Shafiee Ardestani M; Khoobi M; Ostad SN; Dorkoosh FA; Akbari Javar H; Amanlou M
    Onco Targets Ther; 2016; 9():7315-7330. PubMed ID: 27980423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
    Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
    Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer Tethered Bio-Responsive Mesoporous Silica Nanoparticles for Efficient Targeted Delivery of Paclitaxel to Treat Ovarian Cancer Cells.
    Salve R; Kumar P; Chaudhari BP; Gajbhiye V
    J Pharm Sci; 2023 May; 112(5):1450-1459. PubMed ID: 36669561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of Chitosan Oligosaccharide-Loaded Glycyrrhetinic Acid Functionalized Mesoporous Silica Nanoparticles and In Vitro Verification of the Treatment of APAP-Induced Liver Injury.
    Guo X; Zhang C; Bai Y; Che Q; Cao H; Guo J; Su Z
    Molecules; 2023 May; 28(10):. PubMed ID: 37241887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An optimized mesoporous silica nanosphere-based carrier system with chemically removable Au nanoparticle caps for redox-stimulated and targeted drug delivery.
    Zhang L; Wei F; Al-Ammari A; Sun D
    Nanotechnology; 2020 Nov; 31(47):475102. PubMed ID: 32413886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic Acid and PEI Modified Mesoporous Silica for Targeted Delivery of Curcumin.
    Sun X; Wang N; Yang LY; Ouyang XK; Huang F
    Pharmaceutics; 2019 Aug; 11(9):. PubMed ID: 31450762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment.
    Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Mesoporous Silica Nanoparticle Delivery Systems in Chemo-Based Combination Cancer Therapies.
    Gao Y; Gao D; Shen J; Wang Q
    Front Chem; 2020; 8():598722. PubMed ID: 33330389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of curcumin in breast cancer cells via hyaluronic acid modified mesoporous silica nanoparticle to enhance anticancer efficiency.
    Ghosh S; Dutta S; Sarkar A; Kundu M; Sil PC
    Colloids Surf B Biointerfaces; 2021 Jan; 197():111404. PubMed ID: 33142257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Study on Folate-Targeted Mesoporous Silica Nanoparticles Loaded with 5-Fluorouracil for the Enhanced Treatment of Gynecological Cancers.
    Almomen A; Alhowyan A
    J Funct Biomater; 2024 Mar; 15(3):. PubMed ID: 38535267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
    Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
    Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.